Audited financial results of the company for the year ended March 31, 2026

Results View source PDF Explain this filing

CHOLAHLDNG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.6%Reaction day

₹1757.00

prior close

₹1781.60

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.2%+1.4% vs market

Investment Company peers, median of 62sector-0.4%+2.0% vs sector

On the reaction day the stock moved 1.4 pts more than Nifty Smallcap 250 and 2.0 pts more than its Investment Company peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.0

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.6+0.2+1.4-0.4+2.0

Next day

+0.9-0.9+1.8-1.6+2.5

-1.8-3.9+2.0-4.3+2.4

-3.5-3.6+0.1-3.8+0.3

-4.1-3.6-0.5-4.4+0.3

-5.8-3.9-1.8-4.9-0.9

-5.0-4.3-0.7-5.3+0.4

15d

-13.3-3.2-10.1-5.3-8.0

-19.5-3.8-15.7-6.6-12.9

-6.2+1.1-7.3-5.1-1.1

-7.9+5.4-13.3-3.6-4.3

UpDownMarket · Nifty Smallcap 250Sector · Investment Company peers, median of 62Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Cholamandalam Financial Holdings reported strong audited results for FY26. Consolidated total income grew 18% to Rs. 39,576 Cr and consolidated PAT rose 16% to Rs. 5,485 Cr. The major subsidiary CIFCL (43.76% stake) saw disbursements jump 25% to Rs. 32,913 Cr in Q4 and PAT grow 23% to Rs. 5,220 Cr for the year, with assets under management up 21% to Rs. 2,42,630 Cr. However, the general insurance subsidiary CMSGICL (60% stake) saw PAT decline 48% to Rs. 253 Cr due to fair value changes in equity, posting a Q4 loss of Rs. 5 Cr versus profit of Rs. 118 Cr in Q4 FY25. The Board recommended a dividend of Rs. 1.30 per share.

Likely market impact

Strong performance in the core NBFC business with 23% PAT growth and 25% disbursement growth is positive for shareholders, though the insurance subsidiary's profitability decline and fair value losses warrant monitoring.